Related Experiment Video

Updated: May 21, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

15.8K

Resmetirom: Steatosis Down, Fibrosis Out, Peace of Mind In

Prowpanga Udompap1,2

  • 1Department of Medicine, Minneapolis VA Medical Center, Minneapolis, Minnesota, USA.

Hepatology (Baltimore, Md.)
|March 17, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

11.8K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

724

Related Experiment Videos

Last Updated: May 21, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

15.8K
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

11.8K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

724

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

492
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
492

Articles linked to this work by shared authors, journal, and citation graph.

Viral Hepatitis Among African Immigrants with Hepatocellular Carcinoma in Minnesota: High Prevalence Yet Low Awareness.

Journal of immigrant and minority health·2022

Performance of American Gastroenterological Association Clinical Care Pathway for the risk stratification of patients with nonalcoholic fatty liver disease in the US population.

Hepatology (Baltimore, Md.)·2022

Development of Hepatocellular Carcinoma in Patients With Suppressed Viral Replication: Changes in Risk Over Time.

Clinical liver disease·2020

Prospective comparison of transient elastography, point shear wave elastography, APRI and FIB-4 for staging liver fibrosis in chronic viral hepatitis.

Journal of viral hepatitis·2019

An international multicenter analysis of the outcome of pediatric first variceal hemorrhage.

Hepatology (Baltimore, Md.)·2026

AASLD EXPO: Liver biopsy.

Hepatology (Baltimore, Md.)·2026

Efficacy and safety of an 8-week bemnifosbuvir and ruzasvir regimen in chronic hepatitis C: Results from a Phase 2 study.

Hepatology (Baltimore, Md.)·2026

TESERA: morphologic subtyping and prognostic stratification of hepatocellular carcinoma from H&E whole-slide images.

Hepatology (Baltimore, Md.)·2026

Reciprocal cross-species infection potential of human and domestic cat hepatitis B viruses.

Hepatology (Baltimore, Md.)·2026

The hepatic sinusoid as a regulatory niche: From cellular specialization to precision hepatology.

Hepatology (Baltimore, Md.)·2026

Gut-brain axis dysfunction in Parkinson's disease: a meta-analysis of microbiome dysbiosis and intestinal barrier markers.

Frontiers in medicine·2026

D-Mannose treats obesity by increasing adipose Treg cells and suppressing gut Firmicutes.

bioRxiv : the preprint server for biology·2026

The Gut-Brain Axis in Parkinson's Disease: From Clinical Observation toward Mechanism-Based Precision Medicine.

Movement disorders : official journal of the Movement Disorder Society·2026

Thyroid Dysfunction and Its Association with Glycemic Control in Patients with Type 2 Diabetes Mellitus (T2DM): A Systematic Review and Meta-Analysis.

Acta medica Indonesiana·2026

Gastroparesis Phenotyping: Current Methods and Emerging Opportunities With Magnetic Resonance Imaging.

Neurogastroenterology and motility·2026

Optimizing metabolic health through deep-phenotyping-based personalized nutrition.

Nature reviews. Endocrinology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us